MANGALAM DRUG & CHEM LTD Financial Ratios
MANGALAM · Healthcare · Current price ₹30.6
P/E ratio
7.0x
P/B ratio
0.5x
ROE
4.7%
ROCE
8.0%
Debt / Equity
0.64
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 7.0x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.5x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 4.7% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 8.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.64 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with MANGALAM DRUG & CHEM LTD's latest numbers.
MANGALAM DRUG & CHEM LTD profitability
MANGALAM DRUG & CHEM LTD generates a return on equity of 4.7% and a return on capital employed of 8.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.64 and a P/E of 7.0x, MANGALAM DRUG & CHEM LTD is moderately leveraged. Our overall business-quality score for the company is 2.4 / 10.
Understand the ratios
More on MANGALAM DRUG & CHEM LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.